Did I read this right that the net effect of this quarters activities is to reduce the cash balance held by $400k? Increase in revenue is positive but costs to achieve this need to be looked at IMO?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025